Sunday 20 April 2014
Boehringer Ingelheim

Boehringer Ingelheim posts 15pc growth in Mena

Boehringer Ingelheim, a research-driven pharmaceutical company, has achieved a growth of 14 per cent in the Mena region in the last fiscal year. Despite some challenges, the company succeeded in increasing its operating income and


Boehringer, EFSD to fund diabetes research

A new programme unveiled by Boehringer Ingelheim, one of the world's leading pharmaceutical companies, and the European Foundation for the Study of Diabetes (EFSD) has invited European diabetes research projects to send in their applications


Pfizer, BI inhaler may raise risk of death: study

A mist inhaler used to improve breathing in people with lung diseases including chronic bronchitis and emphysema may increase their risk of dying by 52 per cent, US and British researchers said. The increased risk occurred in patients who


Linagliptin 'significantly lowers blood glucose'

Phase III studies of Linagliptin, a compound being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes, showed that the drug significantly lowered blood glucose, a report said. The drug, a dipeptidyl pept


Female sex pill flops with US advisers

A pink sex pill offered little help to women and came with unacceptable risks, US government advisers agreed on Friday, another setback in the search for a drug to boost female libido. German drugmaker Boehringer Ingelheim failed to convin


Boehringer stroke drug proves a winner in trial

Patients at risk of stroke due to an erratic heartbeat should soon have a viable alternative to 50-year-old warfarin, after a new pill from Boehringer Ingelheim beat expectations in a major clinical study. The strong showing for the unlist

 1 2 3 4 5 >  Last ›

calendarCalendar of Events


Buy high quality China wholesale Health & Beauty , Electronics, Sports & Outdoors , Computers, Video Games, Toys & Hobbies Cell Phones, Automobiles and other wholesale products directly from reliable Chinese wholesalers or Factories on